News

Mar 22, 2024

Introduction to FDA Guidance on the Development of SaMD (Chinese version)

Nov 07, 2023

Satety Evaluation of Anti-Amyloid-β Antibodies in Alzheimer’s Disease – ARIA (Chinese version)

Jul 13, 2023

Satety Evaluation of Anti-Amyloid-β Antibodies in Alzheimer’s Disease – ARIA

Feb 14, 2023

The Utilization Situation of Imaging Endpoints – An Imaging Endpoint List –

Aug 25, 2022

The Methodology of Centralized Image Interpretation and Roles of an Imaging CRO: Centralized Image Interpretation Variations​

Aug 08, 2022

The Methodology of Centralized Image Interpretation and Roles of an Imaging CRO: An Overview

Jun 17, 2022

The Development of Software as a Medical Device (SaMD) -Clarification of Clinical Significance-

May 19, 2022

Publication Notice Clinical Trials for ​Medical Imaging Diagnostic Decision Support Systems​ – The Social Implementation of Medical Artificial Intelligence -​

Apr 20, 2022

Publication Notice Clinical Application of a Brain Image Analysis Program for Multiple Sclerosis Part 3 Clinical Significance of “Brain Volume Visualization”: A Treatment Strategy for Long-Term Prognosis

Mar 01, 2022

Publication Notice Clinical Application of a Brain Image Analysis Program for Multiple Sclerosis Part 2: The Usefulness in Multiple Sclerosis Treatment: Potential of Being a Part of a New Evaluation Scale

Feb 01, 2022

Publication Notice Clinical Application of a Brain Image Analysis Program for Multiple Sclerosis Part 1: Multiple Sclerosis and Diagnostic Imaging

Sep 30, 2020

Kobe Cardiovascular Core Laboratory – Introduction on the Service for Clinical Trials Using Intravascular Imaging Endpoints

May 11, 2020

iRECIST Overview

Oct 29, 2019

Clinical Evaluation of AI medical image diagnostic software: The Importance of the Reference Standards